WO1999064046A8 - Agonistes polyvalents, agonistes partiels, agonistes inverses et antagonistes des recepteurs 5-ht¿3? - Google Patents
Agonistes polyvalents, agonistes partiels, agonistes inverses et antagonistes des recepteurs 5-ht¿3?Info
- Publication number
- WO1999064046A8 WO1999064046A8 PCT/US1999/012768 US9912768W WO9964046A8 WO 1999064046 A8 WO1999064046 A8 WO 1999064046A8 US 9912768 W US9912768 W US 9912768W WO 9964046 A8 WO9964046 A8 WO 9964046A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agonists
- receptors
- antagonists
- multivalent
- partial
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/301—Anxiety or phobic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/304—Mood disorders, e.g. bipolar, depression
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002321191A CA2321191A1 (fr) | 1998-06-08 | 1999-06-08 | Agonistes polyvalents, agonistes partiels, agonistes inverses et antagonistes des recepteurs 5-ht3 |
EP99928450A EP1085888A1 (fr) | 1998-06-08 | 1999-06-08 | Agonistes polyvalents, agonistes partiels, agonistes inverses et antagonistes des recepteurs 5-ht 3? |
AU45514/99A AU4551499A (en) | 1998-06-08 | 1999-06-08 | Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-HT3 receptors |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8846698P | 1998-06-08 | 1998-06-08 | |
US60/088,466 | 1998-06-08 | ||
US9293898P | 1998-07-15 | 1998-07-15 | |
US60/092,938 | 1998-07-15 | ||
US12028299P | 1999-02-16 | 1999-02-16 | |
US60/120,282 | 1999-02-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1999064046A1 WO1999064046A1 (fr) | 1999-12-16 |
WO1999064046A9 WO1999064046A9 (fr) | 2000-04-20 |
WO1999064046A8 true WO1999064046A8 (fr) | 2001-08-16 |
Family
ID=27375973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/012768 WO1999064046A1 (fr) | 1998-06-08 | 1999-06-08 | Agonistes polyvalents, agonistes partiels, agonistes inverses et antagonistes des recepteurs 5-ht¿3? |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1085888A1 (fr) |
AU (1) | AU4551499A (fr) |
CA (1) | CA2321191A1 (fr) |
WO (1) | WO1999064046A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003100091A1 (fr) * | 2002-05-24 | 2003-12-04 | Epidauros Biotechnologie Ag | Moyens et methodes de traitement ameliores utilisant des 'setrones' |
GB2398071B (en) * | 2003-01-24 | 2006-06-07 | Synthon Bv | Process for making ondansetron and intermediate thereof |
TWI355936B (en) * | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8730691A (en) * | 1990-09-28 | 1992-04-28 | Neorx Corporation | Polymeric carriers for release of covalently linked agents |
WO1997035195A1 (fr) * | 1996-03-19 | 1997-09-25 | The Salk Institute For Biological Studies | Procede d'identification in vitro de modulateurs de membres de la superfamille des recepteurs des steroides ou thyroides |
-
1999
- 1999-06-08 CA CA002321191A patent/CA2321191A1/fr not_active Abandoned
- 1999-06-08 WO PCT/US1999/012768 patent/WO1999064046A1/fr not_active Application Discontinuation
- 1999-06-08 AU AU45514/99A patent/AU4551499A/en not_active Abandoned
- 1999-06-08 EP EP99928450A patent/EP1085888A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1999064046A1 (fr) | 1999-12-16 |
EP1085888A1 (fr) | 2001-03-28 |
AU4551499A (en) | 1999-12-30 |
WO1999064046A9 (fr) | 2000-04-20 |
CA2321191A1 (fr) | 1999-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG164266A1 (en) | Multibinding agents that modulate ppargamma and rxr receptors | |
WO2003050295A3 (fr) | Essais et mises en oeuvre permettant de determiner et de moduler une activite de liaison hsp90 | |
WO1999063932A3 (fr) | Agents de liaison multiple, modulant le transporteur de 5-ht | |
WO1999003822A8 (fr) | Ligands des recepteurs bicycliques metabotropiques du glutamate | |
DE69728149D1 (de) | Modifizierte liganden für den tie-2-rezeptor | |
ATE361364T1 (de) | Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen | |
WO2003059251A3 (fr) | Composes de ciblage d'anticorps | |
BG103548A (en) | Vitronectine receptor antagonists | |
WO2004035612A3 (fr) | Composition, procede et utilisation de biomateriaux bifonctionnels | |
WO2001096565A3 (fr) | Liant | |
ATE235444T1 (de) | Übergangsmetallkomplexe als linkergruppe | |
IL141158A0 (en) | A humanized immunoglobulin which binds to human von willebrand factor | |
PT1137413E (pt) | Antagonistas nao-peptidicos do receptor de glp-1 e metodos de utilizacao | |
WO2006010142A3 (fr) | Composes de modulation des recepteurs des mineralocorticoides et methodes associees | |
MY133390A (en) | Azabicyclic 5ht1 receptor ligands | |
WO1999064046A8 (fr) | Agonistes polyvalents, agonistes partiels, agonistes inverses et antagonistes des recepteurs 5-ht¿3? | |
WO2002039118A8 (fr) | Procedes de criblage de mimetiques morphogenetiques osseux | |
SE9804175D0 (sv) | New assay | |
AUPP020297A0 (en) | A novel receptor, and compounds which bind thereto | |
EE200300092A (et) | EDb-fibronektiinidomeeni retseptor | |
WO2001085930A3 (fr) | Procedes et composes pour moduler la liaison ligand-recepteur de melanocortine et l'activite correspondante | |
WO2001044439A3 (fr) | Nouvelles analyses biologiques | |
EP0971885A4 (fr) | Procede destine a la preparation de composes de type indane | |
DE69803883D1 (de) | Neue verbindungen, welche antagonisten sind für p2-purinorezeptor 7-transmembran (tm) g-protein gekoppelte rezeptoren | |
ECSP993004A (es) | AGENTES MULTIAGLUTINANTES QUE MODULAN RECEPTORES PPARy Y RXR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1-130, DESCRIPTION, REPLACED BY NEW PAGES 1-130; PAGES 131-145, CLAIMS, REPLACED BY NEW PAGES131-145; PAGES 1/8-8/8, DRAWINGS, REPLACED BY NEW PAGES 1/8-8/8; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2321191 Country of ref document: CA Ref country code: CA Ref document number: 2321191 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999928450 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999928450 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 50/99 UNDER (81) ADD "ZA" |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999928450 Country of ref document: EP |